I thought one of the big come-ons of Obamacare was the elimination of caps.
Of course, it can be argued that this is a drug-cap rather than a medical services cap, but if you’re sick, WTF is the difference?
That’s not to say I don’t understand the need (if expressly disclosed) of some high-level cap, but $250/month is ridiculously low. It’s as if (could it be?) the insurance companies and the drug companies are fighting over some scraps here.
That would mean the pharmaceutical companies can charge whatever they want for the drugs, and only those who can afford their $250/month part of the cost can use it. It sounds like a lose-lose for the the consumer and a win for the pharmaceutical and insurance industry.